Merck & Co’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.01M Hold
1,483,758
0.47% 10
2025
Q1
$1.07M Hold
1,483,758
0.65% 10
2024
Q4
$1.42M Buy
+1,483,758
New +$1.42M 0.55% 9